美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corgi Genomics & Precision Medicine ETF

35.13

+0.10250.29%

成交量：213

成交額：7,554

市值：263.49萬

市盈率：- -

高：35.45

開：35.45

低：35.13

收：35.03

52周最高：36.54

52周最低：23.88

股本：7.50萬

流通股本：7.50萬

量比：1.00

換手率：0.28%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Corgi Genomics & Precision Medicine ETF

交易所：

CBOE

成立時間：

2026

員工人數：

- -

公司地址：

200 West Madison Avenue,Suite 3810,Chicago,Illinois,United States

官網：

http://www.medgenics.com

郵編：

60606-3465

電話：

傳真：

- -

簡介：

Medgenics, Inc.於2000年1月27日在特拉華州成立，其全資附屬公司 Medgenics Medical(以色列）Limited在以色列國依法成立。該公司從事於醫療技術和治療，開發專有創新技術平台，為一千多億美元的蛋白質療法市場提供新的療法。其BiopumpTM平台技術將患者的真皮組織轉成可形成蛋白質的“生物泵”，以在患者體內持續生產治療性蛋白質。當植入患者的皮下組織時，可以提供數月的蛋白療法，而不需要一系列頻繁注射。其Biopump平台技術已被驗證可以使用EPODURETM為貧血治療提供促紅細胞生成素（EPO），且貧血患者的血紅蛋白显示出高水平和穩定性，而這些患者大都是在I/II期用藥達6個月及以上的慢性腎臟病（CKD）患者，且試驗結果显示其中一個病人在長達36月內穩定在高血紅蛋白水平。其Biopump是組織微泵（MO），形成於患者的牙籤大小的皮膚組織，可以產生並分泌特定的蛋白質。該公司已經開發出名為DermaVac的專有設備，以方便微泵的去除和Biopumps的植入。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/GNMX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"GNMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","market":"US","secType":"STK","nameCN":"Corgi Genomics & Precision Medicine ETF","latestPrice":35.1325,"timestamp":1789588800000,"preClose":35.03,"halted":0,"volume":213,"delay":0,"changeRate":0.002926063374250618,"floatShares":75000,"shares":75000,"eps":0,"marketStatus":"盤前交易","change":0.1025,"latestTime":"09-17 04:08:16 EDT","open":35.45,"high":35.45,"low":35.1325,"amount":7554,"amplitude":0.009064,"askPrice":54.82,"askSize":100,"bidPrice":15.45,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1302235200000,"exchange":"CBOE","adjPreClose":35.1325,"nav":35.01,"aum":2625750,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.45,"preClose":35.1325,"latestTime":"16:10 EDT","volume":6,"amount":210.795,"timestamp":1789589404166,"change":0.3175,"changeRate":0.009037,"amplitude":0},"volumeRatio":1.0028255669672084,"impliedVol":0.4272,"impliedVolPercentile":0.7831},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","floatShares":75000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0028255669672084,"shares":75000,"dividePrice":0,"high":35.45,"amplitude":0.009064,"preClose":35.03,"low":35.1325,"week52Low":23.88,"pbRate":"--","week52High":36.5366,"institutionHeld":0,"latestPrice":35.1325,"eps":0,"divideRate":0,"volume":213,"delay":0,"ttmEps":0,"open":35.45,"prevYearClose":25.56,"prevWeekClose":34.1467,"prevMonthClose":35.0802,"prevQuarterClose":31.0879,"fiveDayClose":34.4,"twentyDayClose":32.1297,"sixtyDayClose":28.0485},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNMX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNMX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1992790800,"yearFounded":2026,"address":"200 West Madison Avenue,Suite 3810,Chicago,Illinois,United States","zipCode":"60606-3465","officePhone":"855 552 6744"},"stockCompanyDetail":{"websiteUrl":"http://www.medgenics.com","stockEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":0.0868},{"period":"3month","weight":0.2812},{"period":"6month","weight":0.3745},{"period":"ytd","weight":0.3745}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0241},{"period":"3month","weight":0.0098},{"period":"6month","weight":0.1626},{"period":"1year","weight":0.1425},{"period":"ytd","weight":0.1058}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Medgenics, Inc.於2000年1月27日在特拉華州成立，其全資附屬公司 Medgenics Medical(以色列）Limited在以色列國依法成立。該公司從事於醫療技術和治療，開發專有創新技術平台，為一千多億美元的蛋白質療法市場提供新的療法。其BiopumpTM平台技術將患者的真皮組織轉成可形成蛋白質的“生物泵”，以在患者體內持續生產治療性蛋白質。當植入患者的皮下組織時，可以提供數月的蛋白療法，而不需要一系列頻繁注射。其Biopump平台技術已被驗證可以使用EPODURETM為貧血治療提供促紅細胞生成素（EPO），且貧血患者的血紅蛋白显示出高水平和穩定性，而這些患者大都是在I/II期用藥達6個月及以上的慢性腎臟病（CKD）患者，且試驗結果显示其中一個病人在長達36月內穩定在高血紅蛋白水平。其Biopump是組織微泵（MO），形成於患者的牙籤大小的皮膚組織，可以產生並分泌特定的蛋白質。該公司已經開發出名為DermaVac的專有設備，以方便微泵的去除和Biopumps的植入。","exchange":"CBOE","name":"Corgi Genomics & Precision Medicine ETF","nameEN":"Corgi Genomics & Precision Medicine ETF"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":null}}